WHAT IS OSTEOPOROSIS?
Osteoporosis is a disease which makes bones weak and fragile. This greatly increases the risk of breaking a bone even after a minor fall or bump. The disease has no obvious symptoms, so many people don’t know they have osteoporosis until they suffer a fracture. Fractures can be life-altering, causing pain, disability and loss of independence. That’s why it’s important to prevent osteoporosis!
Meetings & events
CAPTURE THE FRACTURE® (CTF) PARTNERSHIP
This landmark IOF initiative is supported by Amgen and UCB in collaboration with the University of Oxford. It aims to reduce the number of costly and life-altering secondary fractures by advancing national and institutional policy change, by increasing the quality and sustainability of Post-fracture Care (PFC) Coordination Programs, and by doubling the number of PFC programs by 2022.
IOF OSTEOPOROSIS RISK CHECK
The IOF Osteoporosis Risk Check is now available online in 34 languages. This quick and easy-to-use online questionnaire will help you recognize whether you have any key osteoporosis risk factors which indicate the need for testing.
BROKEN BONES, BROKEN LIVES
The fragility fracture crisis in six European countries
This important new report, with country-specific editions, explores the clinical, societal, and cost burden associated with fragility fractures across six major European countries: France, Germany, Italy, Spain, Sweden and the UK.
The reports serve as a roadmap to assist policymakers in reducing the number of fractures and their impact on patients and their healthcare systems.
HIPGEN is a multicenter phase III trial which aims to bring the first regenerative therapy for improving recovery following a surgically treated injury to market approval. The new innovative therapy proposed (which is in advanced clinical development stage) is called allogenic placental cell therapy with PLX-PAD cells for the enhanced recovery following hip fracture surgery.